MBG Selenate Lying on Belly

From MagnetoWiki
Revision as of 10:33, 29 June 2023 by MBass (talk | contribs) (Creating wiki page for LOB experiments)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Selenate modulation of LiCl-induced Lying-on-Belly

Background

Sodium Selenate (Na2Se04) activates PP2A (1).

  • CTA and Selenate experiments show that male Sprague Dawley rats given systemic injections of 0.5mg/kg sodium selenate two hours before taste aversion conditioning form attenuated taste aversions that extinguish rapidly. Selenate also decreases LiCl-induced phospho-MAP kinase in the NTS and lateral PBN.

Agenda

Results

References

Corcoran NM, Martin D, Hutter-Paier B, Windisch M, Nguyen T, Nheu L, Sundstrom LE, Costello AJ, Hovens CM. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer’s disease model. Journal of Clinical Neuroscience 17: 1025- 1033, 2010.[1]


People

Marena Bass

Retrieved from "https://wiki.houptlab.org/index.php?title=MBG_Selenate_Lying_on_Belly&oldid=3090"